A panel of female medical professionals will discuss the
clinical evidence of Kerecis’ products in surgical and outpatient
settings
Kerecis, the pioneer in the use of fish skin and fatty acids for
tissue regeneration and protection, will unveil its latest
scientific and clinical updates, including trial results, at the
upcoming Symposium on Advanced Wound Care (SAWC) Spring. The
company will offer educational symposiums, a hands-on skills lab,
an interactive poster session, a cultural event, and a panel
discussion of female medical professionals. Kerecis will exhibit at
booth 419 at SAWC, which will take place from May 14 to 18 in
Orlando, Florida.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240514761935/en/
Kerecis' ongoing research and data
underscore significantly improved healing times, reduced
complications, and enhanced patient outcomes for the company's
medical fish skin across different clinical settings. (Photo:
Business Wire)
“The recent abstracts and case studies provide compelling
evidence of the efficacy of our products in wound management and
add to our growing body of clinical evidence,” said Fertram
Sigurjonsson, founder and CEO of Kerecis. “Our ongoing research and
data underscore significantly improved healing times, reduced
complications, and enhanced patient outcomes across different
clinical settings. These findings reaffirm our leadership in
regenerative medicine and highlight our commitment to scientific
excellence and the tangible benefits our technology brings
patients,” he added.
Symposium on Fish-Skin Graft Applications
A symposium entitled “Diving into the Diverse Applications of
Fish-Skin Grafts: Head to Toe” will be led by Dr. John Lantis and
Dr. Simon Simmon, a specialist in pressure injuries. The session
will explore the use of Kerecis products across various medical
specialties including Mohs surgery, pressure injuries, and venous
leg ulcers. The symposium will take place Thursday, May 16, from
10:30 a.m. to 11:30 a.m. in Magnolia 10-12.
Symposium on Clinical Evidence
A 30-minute symposium entitled “Clinical Evidence of
Fish-Skin-Graft Applications” will feature an all-female panel
including Thea Price, MD; Lizzy Faust, FNP, WOCN; and Roxana Reyna,
NP. This session will occur on Wednesday, May 15, from 11:45 a.m.
to 12:15 p.m. in the Canary 4 Foyer.
Innovative Research and Techniques
During a hands-on skills lab, Kerecis medical affairs program
managers will demonstrate Kerecis products, highlighting advanced
applications in real-world clinical settings. The skills lab will
take place Friday, May 17, from 2:15 p.m. to 4:25 p.m. in Crystal
Ballroom G1.
Cultural Connection Through a Taste of Iceland
The “Taste of Iceland” event will allow participants to explore
Icelandic culture and its connection to Kerecis innovations. This
popular event will take place Thursday, May 16, from 5 p.m. to 7:15
p.m. in Magnolia 19-21.
Poster Presentations
Additionally, 24 posters will detail advancements and case
studies involving Kerecis products. The following abstracts will be
presented on Thursday, May 16, from 7:30 p.m. to 8:30 p.m. at
Sabal.
CS-022: Vitaliya Boyar, MD, Healing Complex Neonatal
Dehisced Surgical Wounds with Fish Skin Graft
CS-025: Richard Bruno, DPM, Utility of Fish Xenograft in
Diabetic Plantar Foot Ulcerations
CS-026: Richard Bruno, DPM, Fish Skin Xenografts
Facilitating the Healing of Complex Achilles Tendon Wounds
CS-027: Richard Bruno, DPM, Fish Skin Xenografts in the
Management of Gas Gangrene Foot Infections
CS-028: Richard Bruno, DPM, Association of Hemoglobin A1c
and Wound Healing with Application of Omega-3 Fatty Acid Fish
Skin
CS-072: Ronald Guberman, DPM, Case Series of Complex
Diabetic Ulcers Healed With Fish Skin Grafts
CS-076: Mary Hanley, MD, Healing a Large Moh’s Surgical
Wound Due to Squamous Cell Skin Cancer with Icelandic Cod Fish
Skin
CS-083: Kevin Hopkins, MD, Successful Use of
Decellularized Piscine Graft in a Pediatric Extensive Wound
Reconstruction
CS-097: Patrick McEneaney, DPM, Open Midfoot
Fracture/Dislocation Wound Healed with a Fish Skin Graft
CS-107: Luis Navazo, MD, Application of Intact Fish Skin
Graft to Support Healing of a Chronic Sacral Ulceration
CS-108: Luis Navazo, MD, The Use of Intact Fish Skin
Xenograft to Support Healing in a Nonhealing Ulceration in
Quadriplegic Patient
CS-109: Luis Navazo, MD, Application of Fish Skin Grafts
on Persistent Lower Extremity Ulceration
CS-110: Luis Navazo, MD, The Use of Intact Fish Skin
Graft in the Treatment of a Third-Degree Burn Injury
CS-113: Nikul Panchal, DPM, Fragmented Fish Skin Graft to
Heal Wounds Due to “Tranq” Injections
CS-114: Nikul Panchal, DPM, Fragmented Fish Skin Graft to
Treat Large Soft Tissue Defects Due to Gas Gangrene
CS-116: Dhiren Patel, MD, Use of Fish Skin Xenograft in a
Patient with Bullous Pemphigoid
CS-119: Thea Price, MD, When Granulation Really Matters:
Codfish Skin Graft (CFSG) Rapidly Fills Soft Tissue Defects
CS-126: Roxana Reyna, NP, Successful Use of Fish Skin
Graft in Neonatal and Pediatric Wounds
CS-144: Karl Stark, MD, Application of Fish Skin Graft to
Salvage a Complex Foot Wound with Loss of the Majority of the
Dorsum and Heel of the Foot Resulting from Necrotizing
Fasciitis
CS-148: Mark Suski, MD, Successful Staged Reconstruction
of a Large Scalp Defect with Exposed Cranium Secondary to a Rare
Cutaneous Metastasis from Urothelial Bladder Carcinoma Utilizing
Fish Skin Xenografts
CS-149: Mark Suski, MD, Fish Skin Graft for the Treatment
of Bilateral Burns in an Aging Patient
CS-152: Roland Tolliver, DPM, Management of an
Intractable Ulcer of the Achilles Tendon with Fish Skin Grafting: a
Case Report
CS-161: Christopher Winters, DPM, Application of Novel
Fish Skin Graft in the Foot & Ankle: A Retrospective Case
Series
CS-164: Marcus Yarbrough, MD, Outpatient Reconstruction
of Traumatic Dog Bite Avulsion Injuries of the Lower Extremity with
Kerecis Acellular Fish Graft and Negative Pressure Wound Therapy in
a Two-stage Procedure
About Kerecis
Kerecis develops products from fish skin and fatty acids for
cellular therapy, tissue regeneration, and protection. When grafted
onto damaged human tissue or implanted, the patented material
supports the body’s own processes to heal and regenerate. Because
no disease-transfer risk exists between cold-water fish and humans,
the Kerecis fish skin is only gently processed and retains its
similarity to human tissue. The gentle processing preserves the
skin’s original three-dimensional structure, maintaining its
inherent natural strength, complexity, and molecules (such as fatty
acids). Clinical studies have found that the Kerecis products heal
wounds faster than competing products and are cost effective.
Kerecis is the only approved manufacturer of medical devices
containing intact fish skin in the world.
Kerecis is the fastest-growing and one of the top five companies
in the U.S. biologics-skin and dermal-substitute market, according
to SmartTRAK Business Intelligence. Kerecis’ expanding product
portfolio includes SurgiBind®/SurgiClose®, which are used for
reconstructive surgery in hospital operating rooms; GraftGuide®,
which is mostly sold to burn centers; and MariGen® and Shield™,
which are sold to healthcare facilities to treat chronic wounds
such as diabetic wounds, as well as post-Moh's surgery wounds.
Kerecis is committed to the United Nations Sustainable
Development Goals. The fish skin used in Kerecis’ products derives
from wild and sustainable fish stock caught in pristine Icelandic
waters and processed with 100% renewable energy in the town of
Isafjordur, close to the Arctic Circle. Kerecis is part of
Coloplast, the leading global supplier of intimate healthcare
products. For more information, visit https://www.kerecis.com.
Trademarks and registered trademarks are the property of their
respective owners.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240514761935/en/
Kay Paumier Communications Plus kay@communicationsplus.net
408-370-1243 (office) 408-806-1177 (mobile)